These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 26243578)
1. Fracture of Bioresorbable Vascular Scaffold After Side-Branch Balloon Dilation in Bifurcation Coronary Narrowings. Pan M; Romero M; Ojeda S; Suarez de Lezo J; Segura J; Mazuelos F; Martin P; Medina A; Suarez de Lezo J Am J Cardiol; 2015 Oct; 116(7):1045-9. PubMed ID: 26243578 [TBL] [Abstract][Full Text] [Related]
2. The absorb bioresorbable vascular scaffold in coronary bifurcations: insights from bench testing. Džavík V; Colombo A JACC Cardiovasc Interv; 2014 Jan; 7(1):81-8. PubMed ID: 24332424 [TBL] [Abstract][Full Text] [Related]
3. ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance. Mattesini A; Secco GG; Dall'Ara G; Ghione M; Rama-Merchan JC; Lupi A; Viceconte N; Lindsay AC; De Silva R; Foin N; Naganuma T; Valente S; Colombo A; Di Mario C JACC Cardiovasc Interv; 2014 Jul; 7(7):741-50. PubMed ID: 25060016 [TBL] [Abstract][Full Text] [Related]
4. Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres. Fabris E; Caiazzo G; Kilic ID; Serdoz R; Secco GG; Sinagra G; Lee R; Foin N; Di Mario C Catheter Cardiovasc Interv; 2016 Apr; 87(5):839-46. PubMed ID: 26370357 [TBL] [Abstract][Full Text] [Related]
5. Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation. Tanaka A; Jabbour RJ; Kawamoto H; Mangieri A; Pagnesi M; Montalto C; Chieffo A; Carlino M; Montorfano M; Latib A; Colombo A Catheter Cardiovasc Interv; 2016 Nov; 88(6):865-870. PubMed ID: 27219102 [TBL] [Abstract][Full Text] [Related]
6. The duration of balloon inflation affects the luminal diameter of coronary segments after bioresorbable vascular scaffolds deployment. Sorrentino S; De Rosa S; Ambrosio G; Mongiardo A; Spaccarotella C; Polimeni A; Sabatino J; Torella D; Caiazzo G; Indolfi C BMC Cardiovasc Disord; 2015 Dec; 15():169. PubMed ID: 26654975 [TBL] [Abstract][Full Text] [Related]
7. Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions). Onuma Y; Serruys PW; Muramatsu T; Nakatani S; van Geuns RJ; de Bruyne B; Dudek D; Christiansen E; Smits PC; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia HM; Veldhof S; Rapoza R; Ormiston JA JACC Cardiovasc Interv; 2014 Dec; 7(12):1400-11. PubMed ID: 25523532 [TBL] [Abstract][Full Text] [Related]
14. Bioresorbable vascular scaffold thrombosis in a consecutive cohort of 550 patients. Tröbs M; Achenbach S; Röther J; Klinghammer L; Schlundt C Catheter Cardiovasc Interv; 2016 Nov; 88(6):872-880. PubMed ID: 27142643 [TBL] [Abstract][Full Text] [Related]
15. Direct bioresorbable vascular scaffold implantation: Feasibility and midterm results. Suárez de Lezo J; Martín P; Mazuelos F; Nóvoa J; Ojeda S; Pan M; Segura J; Hernández E; Romero M; Melián F; Medina A; Suárez de Lezo J Catheter Cardiovasc Interv; 2016 Apr; 87(5):E173-82. PubMed ID: 26268440 [TBL] [Abstract][Full Text] [Related]
16. Coronary artery perforation at the level of two-overlapping bioresorbable vascular scaffolds: The importance of vessel sizing and scaffold thickness. Pichette M; Chevalier F; Généreux P Catheter Cardiovasc Interv; 2015 Oct; 86(4):686-91. PubMed ID: 26122768 [TBL] [Abstract][Full Text] [Related]
17. Coronary bifurcation lesions: Some questions need an answer to make bioresorbable vascular scaffold technology more "coronary bifurcation-friendly". Piraino D; Buccheri D; Andolina G Int J Cardiol; 2016 Jul; 215():80-3. PubMed ID: 27111164 [No Abstract] [Full Text] [Related]
18. 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials. Muramatsu T; Onuma Y; van Geuns RJ; Chevalier B; Patel TM; Seth A; Diletti R; García-García HM; Dorange CC; Veldhof S; Cheong WF; Ozaki Y; Whitbourn R; Bartorelli A; Stone GW; Abizaid A; Serruys PW; ; ; ; ; ; JACC Cardiovasc Interv; 2014 May; 7(5):482-93. PubMed ID: 24746650 [TBL] [Abstract][Full Text] [Related]